REFERENCES
1. Libby P, Pasterkamp G, Crea F, Kyung Jang Ik. Reassessing the
Mechanisms of Acute Coronary Syndromes: The “Vulnerable Plaque” and
Superficial Erosion. Circ Res 2019; 124: 150-160.
2. Braunwald, E. and D.A. Morrow, Unstable angina: is it time for a
requiem? Circulation 2013; 127: 2452-7.
3. Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs, J, Bhatt DL
et al. 2020 ESC Guidelines for the management of acute coronary
syndromes in patients presenting without persistent ST-segment
elevation: The Task Force for the management of acute coronary syndromes
in patients presenting without persistent ST-segment elevation of the
European Society of Cardiology. Eur Heart J 2020; 00 1-79
doi:10.1093/eurheartj/ehaa575
4. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F,
et al. 2015 ESC Guidelines for the management of acute coronary
syndromes in patients presenting without persistent ST-segment
elevation: Task Force for the Management of Acute Coronary Syndromes in
Patients Presenting without Persistent ST-Segment Elevation of the
European Society of Cardiology (ESC). Eur Heart J 2016; 37:267-315.
5. O’Donoghue M, Boden WE, Braunwald E, Cannon CP, Clayton TC, Winter
RJ, et al. Early invasive vs conservative treatment strategies in women
and men with unstable angina and non-ST-segment elevation myocardial
infarction: a meta-analysis. JAMA 2008; 300: 71-80.
6. O’Donoghue ML, Morrow DA, Cannon CP, Jarolim P, Desai NR, Sherwood
MW, et al. Multimarker Risk Stratification in Patients With Acute
Myocardial Infarction. J Am Heart Assoc 2016;5:e002586.
7. Morawiec B, Kawecki D. Copeptin: a new marker in cardiology. J
Cardiovasc Med (Hagerstown) 2013;14:19-25.
8. Lui CT, Lam H, Cheung KH, Yip SF, Tsui KL, Kam CW, et al. Role of
copeptin in dual-cardiac marker strategy for patients with chest pain
presented to ED. Am J Emerg Med 2015;33:1732-6.
9. Khan SQ, Dhillon OS, O’Brien RJ, Struck J, Quinn PA, Morgenthaler NG,
et al. C-terminal provasopressin (copeptin) as a novel and prognostic
marker in acute myocardial infarction: Leicester Acute Myocardial
Infarction Peptide (LAMP) study. Circulation 2007;115: 2103-10.
10. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H,
Morgenthaler NG, et al. Incremental value of copeptin for rapid rule out
of acute myocardial infarction. J Am Coll Cardiol 2009;54: 60-8.
11. Eagle KA, Lim Mj, Dabbaus OH, Pieper KS, Goldberg RJ, Van de Werf
FV, et al. A validated prediction model for all forms of acute coronary
syndrome: estimating the risk of 6-month postdischarge death in an
international registry. JAMA 2004; 291:2727-33.
12. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K,
et al. The SYNTAX Score: an angiographic tool grading the complexity of
coronary artery disease. EuroIntervention 2005;1: 219-27.
13. Basra SS, Virani SS, Paniagua D, Kar B, Jneid H. Acute Coronary
Syndromes: Unstable Angina and Non-ST Elevation Myocardial Infarction.
Heart Fail Clin 2016;12:31-48.
14. Hedayati T, Yadav N, Khanagavi J. Non-ST-Segment Acute Coronary
Syndromes. Cardiol Clin 2018;36:37-52.
15. Morgenthaler NG. Copeptin: a biomarker of cardiovascular and renal
function. Congest Heart Fail 2010; 16 Suppl 1:37-44.
16. Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler Ng,
McCord J, et al. Copeptin helps in the early detection of patients with
acute myocardial infarction: primary results of the CHOPIN trial
(Copeptin Helps in the early detection Of Patients with acute myocardial
INfarction). J Am Coll Cardiol 2013; 62:150-160.
17. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, et al.
Copeptin improves early diagnosis of acute myocardial infarction. J Am
Coll Cardiol 2010;55:2096-106.
18. Wildi K, Zellweger C, Twerenbold R, et al. Incremental value of
copeptin to highly sensitive cardiac Troponin I for rapid rule-out of
myocardial infarction. Int J Cardiol 2015;190:170-176.
19. Balmelli C, Meune C, Twerenbold R, Jaeger C, Reichlin T, Haaf P, et
al. Comparison of the performances of cardiac troponins, including
sensitive assays, and copeptin in the diagnostic of acute myocardial
infarction and long-term prognosis between women and men. Am Heart
journal 2013;166:30-37.
20. Charpentier S, Lepage B, Maupas-Schwalm F, Cinq-Frais C,
Bichard-Bréaud M, Botella JM, et al. Copeptin improves the diagnostic
performance of sensitive troponin I-Ultra but cannot rapidly rule out
non-ST-elevation myocardial infarction at presentation to an emergency
department. Ann Emerg Med 2013; 61:549-558.
21. O’Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine
MS, et al. Prognostic performance of multiple biomarkers in patients
with non-ST-segment elevation acute coronary syndrome: analysis from the
MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less
Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In
Myocardial Infarction 36). J Am Coll Cardiol 2014;63:1644-53.
22. Reinstadler SJ, Klug G, Feistritzer HJ, Mayr A, Harrasser B, Mair J,
et al. Association of copeptin with myocardial infarct size and
myocardial function after ST segment elevation myocardial infarction.
Heart 2013; 99:1525-9.
23. von Haehling S, Papassotiriou J, Morgenthaler NG, Nagel E, Gawaz M,
Bigalke B, et al. Copeptin as a prognostic factor for major adverse
cardiovascular events in patients with coronary artery disease. Int J
Cardiol 2012; 162:27-32.
24. Zellweger C, Wildi K, Twerenbold R, T Reichlin, A Naduvilekoot, J D
Neuhauset, al. Use of copeptin and high-sensitive cardiac troponin T for
diagnosis and prognosis in patients with diabetes mellitus and suspected
acute myocardial infarction. Int J Cardiol 2015; 190:190-197.
25. Afzali D, Erren M, Hermann-Joseph P, Vollert JO, Hertel S,
Waltenberger J, et al. Impact of copeptin on diagnosis, risk
stratification, and intermediate-term prognosis of acute coronary
syndromes. Clin Res Cardiol 2013; 102:755-63.
26. Chenevier-Gobeaux C, Sebbane M, Meune C, Lefebvre S, Dupuy AM,
Lefèvreet G, al. Is high-sensitivity troponin, alone or in combination
with copeptin, sensitive enough for ruling out NSTEMI in very early
presenters at admission? A post hoc analysis performed in emergency
departments. BMJ Open 2019;9:e023994.
27. Morawiec, B. Kawecki D, Przywara-Chowaniec B, Opara M, Muzyk P, Ho
L, et al. Copeptin as a Prognostic Marker in Acute Chest Pain and
Suspected Acute Coronary Syndrome. Dis Markers 2018; 24: 6597387.